12 employees
Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.
2001
$4.4M
from 1 investors over 1 rounds
Intervacc AB raised $4.4M on December 20, 2010
Investors: Knutsson Holdings AB